Quigley Nicholas, Binnie Alexandra, Baig Nadia, Opgenorth Dawn, Senaratne Janek, Sligl Wendy I, Zuege Danny J, Rewa Oleksa, Bagshaw Sean M, Tsang Jennifer, Lau Vincent I
Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta and Alberta Health Services, Edmonton, AB, Canada.
Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, 8440 112 St, Edmonton, AB, T6G 2B7, Canada.
Can J Anaesth. 2024 Mar;71(3):390-399. doi: 10.1007/s12630-023-02669-y. Epub 2023 Dec 21.
Critical care research in Canada is conducted primarily in academically affiliated intensive care units (ICUs) with established research infrastructure. Efforts are made to engage community hospital ICUs in research, although the impacts of their inclusion in clinical research have never been explicitly quantified. We therefore sought to determine the number of additional eligible patients that could be recruited into critical care trials and the change in time to study completion if community ICUs were included in clinical research.
We conducted a decision tree analysis using 2018 Alberta Health Services data. Patient demographics and clinical characteristics for all ICU patients were compared against eligibility criteria from ten landmark, randomized, multicentre critical care trials. Individual patients from academic and community ICUs were assessed for eligibility in each of the ten studies, and decision tree analysis models were built based on prior inclusion and exclusion criteria from those trials.
The number of potentially eligible patients for the ten trials ranged from 2,082 to 10,157. Potentially eligible participants from community ICUs accounted for 40.0% of total potentially eligible participants. The recruitment of community ICU patients in trials would have increased potential enrolment by an average of 64.0%. The inclusion of community ICU patients was predicted to decrease time to trial completion by a mean of 14 months (43% reduction).
Inclusion of community ICU patients in critical care research trials has the potential to substantially increase enrolment and decrease time to trial completion.
加拿大的重症监护研究主要在具有成熟研究基础设施的学术附属重症监护病房(ICU)中进行。尽管社区医院ICU参与临床研究的影响从未得到明确量化,但仍努力促使其参与研究。因此,我们试图确定如果将社区ICU纳入临床研究,可纳入重症监护试验的额外合格患者数量以及研究完成时间的变化。
我们使用2018年艾伯塔省卫生服务数据进行了决策树分析。将所有ICU患者的人口统计学和临床特征与十项具有里程碑意义的随机多中心重症监护试验的纳入标准进行比较。评估学术ICU和社区ICU的个体患者在这十项研究中的纳入资格,并根据这些试验先前的纳入和排除标准建立决策树分析模型。
这十项试验中潜在合格患者的数量在2082至10157之间。社区ICU的潜在合格参与者占潜在合格参与者总数的40.0%。在试验中招募社区ICU患者将使潜在入组人数平均增加64.0%。预计纳入社区ICU患者将使试验完成时间平均缩短14个月(减少43%)。
将社区ICU患者纳入重症监护研究试验有可能大幅增加入组人数并缩短试验完成时间。